Zaleplon Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type (5mg, 10mg); Dosage form (Oral, Intranasal), Impact of covid-19 pandemic.

Report Code: TIPRE00018999 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Zaleplon is a sedative-hypnotic drug, sold under the brand names Sonata, commonly prescribed to treat insomnia. It is a nonbenzodiazepine hypnotic class drug. Zaleplon significantly reduces the time required to fall asleep by improving sleep latency and facilitate sleep induction instead of sleep maintenance. Increasing prevalence of insomnia across the world, rising stress level, and increasing awareness about treatment options for this condition are expected to offer significant opportunities to Zaleplon drug market.

MARKET DYNAMICS

Zaleplon market is driving due to factors such as increase in prevalence of anxiety, seizures, insomnia, and rise in concern for prevention of stress and related conditions. However, factor such as poor efficacy and safety profiles of drug and rise in demand for cost-effective alternative OTC sleep aids are expected to hamper the market growth.

MARKET SCOPE

The Zaleplon market analysis to 2027 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Zaleplon market with detailed market segmentation by product type and dosage form. The Zaleplon market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Zaleplon market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Zaleplon market is segmented on the basis of product type and dosage form. Based on product type, market is segmented as 5mg, 10mg. Based on dosage form, market can be segmented into oral and intranasal.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Zaleplon market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Zaleplon market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Zaleplon market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Zaleplon market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Zaleplon market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as Product Type and Dosage form launches, Product Type and Dosage form approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Zaleplon market are anticipated to have lucrative growth opportunities in the future with the rising demand for Zaleplon in the global market. Below mentioned is the list of few companies engaged in the Zaleplon market.

The report also includes the profiles of key players in Zaleplon market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Aurobindo Pharma
  •  Cipla
  •  Mylan Pharmaceuticals
  •  Roxane Laboratories
  •  Novartis
  •  Teva Pharmaceuticals
  •  Unichem Laboratories
  •  Upsher Smith Laboratories
  •  West Ward Pharmaceutical
  •  Pfizer

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Zaleplon Market - By Product Type
1.3.2 Zaleplon Market - By Dosage form
1.3.3 Zaleplon Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ZALEPLON MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ZALEPLON MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ZALEPLON MARKET - GLOBAL MARKET ANALYSIS
6.1. ZALEPLON - GLOBAL MARKET OVERVIEW
6.2. ZALEPLON - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ZALEPLON MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. 5MG
7.3.1. Overview
7.3.2. 5mg Market Forecast and Analysis
7.4. 10MG
7.4.1. Overview
7.4.2. 10mg Market Forecast and Analysis
8. ZALEPLON MARKET - REVENUE AND FORECASTS TO 2027 - DOSAGE FORM
8.1. OVERVIEW
8.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INTRANASAL
8.4.1. Overview
8.4.2. Intranasal Market Forecast and Analysis
9. ZALEPLON MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Zaleplon Market Overview
9.1.2 North America Zaleplon Market Forecasts and Analysis
9.1.3 North America Zaleplon Market Forecasts and Analysis - By Product Type
9.1.4 North America Zaleplon Market Forecasts and Analysis - By Dosage form
9.1.5 North America Zaleplon Market Forecasts and Analysis - By Countries
9.1.5.1 United States Zaleplon Market
9.1.5.1.1 United States Zaleplon Market by Product Type
9.1.5.1.2 United States Zaleplon Market by Dosage form
9.1.5.2 Canada Zaleplon Market
9.1.5.2.1 Canada Zaleplon Market by Product Type
9.1.5.2.2 Canada Zaleplon Market by Dosage form
9.1.5.3 Mexico Zaleplon Market
9.1.5.3.1 Mexico Zaleplon Market by Product Type
9.1.5.3.2 Mexico Zaleplon Market by Dosage form
9.2. EUROPE
9.2.1 Europe Zaleplon Market Overview
9.2.2 Europe Zaleplon Market Forecasts and Analysis
9.2.3 Europe Zaleplon Market Forecasts and Analysis - By Product Type
9.2.4 Europe Zaleplon Market Forecasts and Analysis - By Dosage form
9.2.5 Europe Zaleplon Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Zaleplon Market
9.2.5.1.1 Germany Zaleplon Market by Product Type
9.2.5.1.2 Germany Zaleplon Market by Dosage form
9.2.5.2 France Zaleplon Market
9.2.5.2.1 France Zaleplon Market by Product Type
9.2.5.2.2 France Zaleplon Market by Dosage form
9.2.5.3 Italy Zaleplon Market
9.2.5.3.1 Italy Zaleplon Market by Product Type
9.2.5.3.2 Italy Zaleplon Market by Dosage form
9.2.5.4 Spain Zaleplon Market
9.2.5.4.1 Spain Zaleplon Market by Product Type
9.2.5.4.2 Spain Zaleplon Market by Dosage form
9.2.5.5 United Kingdom Zaleplon Market
9.2.5.5.1 United Kingdom Zaleplon Market by Product Type
9.2.5.5.2 United Kingdom Zaleplon Market by Dosage form
9.2.5.6 Rest of Europe Zaleplon Market
9.2.5.6.1 Rest of Europe Zaleplon Market by Product Type
9.2.5.6.2 Rest of Europe Zaleplon Market by Dosage form
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Zaleplon Market Overview
9.3.2 Asia-Pacific Zaleplon Market Forecasts and Analysis
9.3.3 Asia-Pacific Zaleplon Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Zaleplon Market Forecasts and Analysis - By Dosage form
9.3.5 Asia-Pacific Zaleplon Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Zaleplon Market
9.3.5.1.1 Australia Zaleplon Market by Product Type
9.3.5.1.2 Australia Zaleplon Market by Dosage form
9.3.5.2 China Zaleplon Market
9.3.5.2.1 China Zaleplon Market by Product Type
9.3.5.2.2 China Zaleplon Market by Dosage form
9.3.5.3 India Zaleplon Market
9.3.5.3.1 India Zaleplon Market by Product Type
9.3.5.3.2 India Zaleplon Market by Dosage form
9.3.5.4 Japan Zaleplon Market
9.3.5.4.1 Japan Zaleplon Market by Product Type
9.3.5.4.2 Japan Zaleplon Market by Dosage form
9.3.5.5 South Korea Zaleplon Market
9.3.5.5.1 South Korea Zaleplon Market by Product Type
9.3.5.5.2 South Korea Zaleplon Market by Dosage form
9.3.5.6 Rest of Asia-Pacific Zaleplon Market
9.3.5.6.1 Rest of Asia-Pacific Zaleplon Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific Zaleplon Market by Dosage form
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Zaleplon Market Overview
9.4.2 Middle East and Africa Zaleplon Market Forecasts and Analysis
9.4.3 Middle East and Africa Zaleplon Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Zaleplon Market Forecasts and Analysis - By Dosage form
9.4.5 Middle East and Africa Zaleplon Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Zaleplon Market
9.4.5.1.1 South Africa Zaleplon Market by Product Type
9.4.5.1.2 South Africa Zaleplon Market by Dosage form
9.4.5.2 Saudi Arabia Zaleplon Market
9.4.5.2.1 Saudi Arabia Zaleplon Market by Product Type
9.4.5.2.2 Saudi Arabia Zaleplon Market by Dosage form
9.4.5.3 U.A.E Zaleplon Market
9.4.5.3.1 U.A.E Zaleplon Market by Product Type
9.4.5.3.2 U.A.E Zaleplon Market by Dosage form
9.4.5.4 Rest of Middle East and Africa Zaleplon Market
9.4.5.4.1 Rest of Middle East and Africa Zaleplon Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa Zaleplon Market by Dosage form
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Zaleplon Market Overview
9.5.2 South and Central America Zaleplon Market Forecasts and Analysis
9.5.3 South and Central America Zaleplon Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Zaleplon Market Forecasts and Analysis - By Dosage form
9.5.5 South and Central America Zaleplon Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Zaleplon Market
9.5.5.1.1 Brazil Zaleplon Market by Product Type
9.5.5.1.2 Brazil Zaleplon Market by Dosage form
9.5.5.2 Argentina Zaleplon Market
9.5.5.2.1 Argentina Zaleplon Market by Product Type
9.5.5.2.2 Argentina Zaleplon Market by Dosage form
9.5.5.3 Rest of South and Central America Zaleplon Market
9.5.5.3.1 Rest of South and Central America Zaleplon Market by Product Type
9.5.5.3.2 Rest of South and Central America Zaleplon Market by Dosage form
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ZALEPLON MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ZALEPLON MARKET, KEY COMPANY PROFILES
12.1. AUROBINDO PHARMA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CIPLA
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MYLAN PHARMACEUTICALS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ROXANE LABORATORIES
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. NOVARTIS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. TEVA PHARMACEUTICALS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. UNICHEM LABORATORIES
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. UPSHER SMITH LABORATORIES
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. WEST WARD PHARMACEUTICAL
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. PFIZER
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Aurobindo Pharma
2. Cipla
3. Mylan Pharmaceuticals
4. Roxane Laboratories
5. Novartis
6. Teva Pharmaceuticals
7. Unichem Laboratories
8. Upsher Smith Laboratories
9. West Ward Pharmaceutical
10. Pfizer
TIPRE00018999
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking